Medical Necessity Determination for Cervical Artificial Disc Replacement (CPT 22856)
Cervical artificial disc replacement at C4-5 and C5-6 is NOT medically necessary for this patient because there is no documented radiologic evidence of segmental instability, which is an absolute contraindication per FDA-approved device criteria and established guidelines.
Critical Missing Requirement: Segmental Instability Assessment
The absence of documented radiologic evidence regarding segmental instability is a disqualifying factor for cervical disc arthroplasty. 1
- FDA-approved cervical disc prostheses (ProDisc-C, ProDisc-C Vivo, ProDisc-C SK) explicitly require that "there is no radiologic evidence of segmental instability" as a mandatory inclusion criterion 2
- The request states the provider is "UNSURE IF PATIENT HAS RADIOLOGIC EVIDENCE OF SEGMENTAL INSTABILITY" - this uncertainty alone disqualifies the patient from artificial disc replacement 1
- Flexion-extension radiographs are required to definitively rule out segmental instability before proceeding with arthroplasty 3
Additional Contraindications Present
Recent Infection History
This patient has a documented recent postoperative infection (June 2025) requiring 6 weeks of IV antibiotics, which represents a significant contraindication to artificial disc placement. 1
- The patient underwent ACDF at C6-7 in June 2025 and developed a postoperative infection 1
- Placing a motion-preserving implant in a patient with recent spinal infection carries unacceptable risk of recurrent infection and implant failure 2
- The timeline from infection treatment (completed approximately August 2025) to proposed surgery (November 2025) is only 3 months - insufficient time to ensure complete resolution 1
Adjacent Level Disease After Recent Fusion
The patient now presents with new C6 radiculopathy "since surgery" at an adjacent level (C5-6) to her recent C6-7 fusion, which fundamentally changes the surgical indication. 1
- MRI shows "degenerative spondylopathy most prominent at C5-C6 where there is moderate canal stenosis and moderate left foraminal stenosis, which is increased from prior" 1
- This represents adjacent segment disease developing within 4-5 months of the index fusion 3
- Performing artificial disc replacement adjacent to a recent fusion site (hybrid construct) is not FDA-approved and lacks long-term outcome data 2
Appropriate Alternative: Anterior Cervical Decompression and Fusion
ACDF at C5-6 (and potentially C4-5 if clinically indicated) is the medically necessary procedure for this patient, not artificial disc replacement. 3, 1
Why ACDF is Indicated:
- Moderate to severe stenosis documented: MRI confirms "moderate canal stenosis and moderate left foraminal stenosis" at C5-6, meeting the severity threshold for surgical intervention 1
- Clinical correlation present: Left C6 radiculopathy with weakness, numbness, and 80% relief from diagnostic injection directly correlates with C5-6 pathology 3, 1
- Failed conservative management: Patient has undergone 5+ months of conservative treatment including Flexeril, gabapentin, oxycodone, and prednisone since June 2025 1, 4
- Functional impairment: Patient reports dropping things, decreased dexterity, and pain radiating to left biceps and thumb, indicating significant functional deficit 1, 4
Evidence Supporting ACDF Over Arthroplasty:
- ACDF provides 80-90% success rates for arm pain relief in cervical radiculopathy 3, 1
- Anterior cervical plating is recommended for 2-level disease to improve arm pain and reduce pseudarthrosis risk 3
- ACDF is specifically indicated for patients with moderate to severe foraminal stenosis when conservative management has failed 1
- The Journal of Neurosurgery reports 90.9% functional improvement following anterior cervical decompression for radiculopathy 3, 1
Addressing the C4-5 Level
The medical necessity for C4-5 intervention is questionable based on available documentation. 1
- No specific imaging findings at C4-5 are documented in the provided MRI report 1
- Clinical symptoms (C6 radiculopathy) do not correlate with C4-5 pathology 3, 1
- Performing fusion at a level without documented moderate-to-severe stenosis is not supported by guidelines 1
- If C4-5 intervention is considered necessary, the surgeon must document specific imaging findings showing moderate-to-severe stenosis and clinical correlation 3, 1
Critical Documentation Deficiencies
Before ANY cervical surgery can be approved, the following must be obtained:
- Flexion-extension cervical spine radiographs to definitively rule out segmental instability at all proposed surgical levels 3
- Detailed C4-5 imaging findings from the MRI report to justify intervention at this level 3, 1
- Documentation of infection resolution including follow-up inflammatory markers (ESR, CRP) and clinical assessment confirming no ongoing infection 1
- Specific conservative treatment timeline with dates, frequency, and response to each modality (currently documented as "since June" which is adequate at 5+ months, but specifics strengthen the case) 1, 4
Common Pitfalls to Avoid
- Do not proceed with artificial disc replacement in the setting of recent infection - this represents an absolute contraindication regardless of other factors 2
- Do not perform hybrid constructs (disc replacement adjacent to fusion) without FDA approval - this is considered investigational 2
- Do not assume stability without flexion-extension films - static MRI cannot adequately assess segmental instability 3
- Do not operate on levels without documented moderate-to-severe stenosis - mild stenosis does not meet surgical thresholds 1
Recommended Approval Path
Approve ACDF at C5-6 (CPT 22551,22552 if applicable, 22845 for instrumentation) contingent on:
- Flexion-extension radiographs confirming no segmental instability 3
- Documentation of complete infection resolution with normal inflammatory markers 1
- Detailed imaging report confirming moderate-to-severe stenosis at C5-6 (already documented) 1
Deny artificial disc replacement (CPT 22856) due to:
- Absence of documented stability assessment (absolute contraindication) 1, 2
- Recent postoperative infection history (relative contraindication) 1
- Adjacent level to recent fusion (not FDA-approved for hybrid construct) 2
Require additional documentation before considering C4-5 intervention: